[RGLS] YoY Annual Result on 31-Dec-2019 [#FY]

Stock
[RGLS] Regulus Therapeutics Inc.
Announcement Date
12-Mar-2020
Financial Year
2019
Quarter
31-Dec-2019 [#FY]
Profit Trend
YoY- 61.83%
Quarter Report
RGLS's Result
RGLS's Financial Summary
View:
Show?
Annual Result
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
Revenue 0 0 10,006 6,832 72 72 1,194 -
PBT -28,322 -27,807 -15,730 -18,591 -48,647 -72,102 -81,840 -16.20%
Tax 1 1 -467 1 62 -197 -4 -
NP -28,323 -27,808 -15,263 -18,592 -48,709 -71,905 -81,836 -16.20%
Tax Rate - - - - - - - -
Total Cost 28,323 27,808 25,269 25,424 48,781 71,977 83,030 -16.40%
Ratio Analysis
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
NP Margin 0.00 0.00 -152.54 -272.13 -67,651.39 -99,868.06 -6,853.94 -
Per Share
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
EPS -1.86 -3.24 -4.36 -10.77 -55.87 -114.70 -185.94 -53.56%
EPS Diluted -1.86 -3.24 -4.36 -10.77 -55.87 -114.70 -185.94 -53.56%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.